Posted inEuronext
Sanofi agrees to acquire Provention Bio Inc. for $2.9 billion
PARIS, FRANCE: Sanofi has entered into an agreement to acquire Provention Bio Inc., for $25/share in cash, representing an equity value of approximately $2.9 billion. The transaction adds an innovative,…